These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38688882)

  • 1. Clinical predictors of Alzheimer's disease-like brain atrophy in individuals with memory complaints.
    Karakasli AA; Ozkan E; Karacam Dogan M; Cap D; Karaosmanoglu A; Karahan S; Zorlu N; Saka E; Ayhan Y
    Brain Behav; 2024 May; 14(5):e3506. PubMed ID: 38688882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns.
    Lerch O; Ferreira D; Stomrud E; van Westen D; Tideman P; Palmqvist S; Mattsson-Carlgren N; Hort J; Hansson O; Westman E
    Alzheimers Res Ther; 2024 Jul; 16(1):153. PubMed ID: 38970077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.
    Arvidsson I; Strandberg O; Palmqvist S; Stomrud E; Cullen N; Janelidze S; Tideman P; Heyden A; Åström K; Hansson O; Mattsson-Carlgren N
    Alzheimers Res Ther; 2024 Mar; 16(1):61. PubMed ID: 38504336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline.
    Morrison C; Dadar M; Shafiee N; Villeneuve S; Louis Collins D;
    Neuroimage Clin; 2022; 33():102923. PubMed ID: 34959049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
    Ten Kate M; Redolfi A; Peira E; Bos I; Vos SJ; Vandenberghe R; Gabel S; Schaeverbeke J; Scheltens P; Blin O; Richardson JC; Bordet R; Wallin A; Eckerstrom C; Molinuevo JL; Engelborghs S; Van Broeckhoven C; Martinez-Lage P; Popp J; Tsolaki M; Verhey FRJ; Baird AL; Legido-Quigley C; Bertram L; Dobricic V; Zetterberg H; Lovestone S; Streffer J; Bianchetti S; Novak GP; Revillard J; Gordon MF; Xie Z; Wottschel V; Frisoni G; Visser PJ; Barkhof F
    Alzheimers Res Ther; 2018 Sep; 10(1):100. PubMed ID: 30261928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
    Miebach L; Wolfsgruber S; Polcher A; Peters O; Menne F; Luther K; Incesoy E; Priller J; Spruth E; Altenstein S; Buerger K; Catak C; Janowitz D; Perneczky R; Utecht J; Laske C; Buchmann M; Schneider A; Fliessbach K; Kalbhen P; Heneka MT; Brosseron F; Spottke A; Roy N; Teipel SJ; Kilimann I; Wiltfang J; Bartels C; Düzel E; Dobisch L; Metzger C; Meiberth D; Ramirez A; Jessen F; Wagner M
    Alzheimers Res Ther; 2019 Jul; 11(1):66. PubMed ID: 31366409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers.
    Giannakopoulos P; Montandon ML; Herrmann FR; Hedderich D; Gaser C; Kellner E; Rodriguez C; Haller S
    Eur Radiol; 2022 Nov; 32(11):7833-7842. PubMed ID: 35486172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
    J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
    J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminution of context association memory structure in subjects with subjective cognitive decline.
    Fan LY; Lai YM; Chen TF; Hsu YC; Chen PY; Huang KZ; Cheng TW; Tseng WI; Hua MS; Chen YF; Chiu MJ
    Hum Brain Mapp; 2018 Jun; 39(6):2549-2562. PubMed ID: 29516634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective Cognitive Decline Below and Above the Age of 60: A Multivariate Study on Neuroimaging, Cognitive, Clinical, and Demographic Measures.
    Cedres N; Machado A; Molina Y; Diaz-Galvan P; Hernández-Cabrera JA; Barroso J; Westman E; Ferreira D
    J Alzheimers Dis; 2019; 68(1):295-309. PubMed ID: 30741680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7T amygdala and hippocampus subfields in volumetry-based associations with memory: A 3-year follow-up study of early Alzheimer's disease.
    Göschel L; Kurz L; Dell'Orco A; Köbe T; Körtvélyessy P; Fillmer A; Aydin S; Riemann LT; Wang H; Ittermann B; Grittner U; Flöel A
    Neuroimage Clin; 2023; 38():103439. PubMed ID: 37253284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of magnetic resonance imaging and neuropsychological assessment in memory clinic patients.
    Schmand B; Rienstra A; Tamminga H; Richard E; van Gool WA; Caan MW; Majoie CB
    J Alzheimers Dis; 2014; 40(2):409-18. PubMed ID: 24473187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
    Lista S; Molinuevo JL; Cavedo E; Rami L; Amouyel P; Teipel SJ; Garaci F; Toschi N; Habert MO; Blennow K; Zetterberg H; O'Bryant SE; Johnson L; Galluzzi S; Bokde AL; Broich K; Herholz K; Bakardjian H; Dubois B; Jessen F; Carrillo MC; Aisen PS; Hampel H
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S171-91. PubMed ID: 26402088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study.
    Hong YJ; Park JW; Lee SB; Kim SH; Kim Y; Ryu DW; Park KW; Yang DW
    Dement Geriatr Cogn Disord; 2021; 50(5):437-445. PubMed ID: 34736258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrum.
    Amaefule CO; Dyrba M; Wolfsgruber S; Polcher A; Schneider A; Fliessbach K; Spottke A; Meiberth D; Preis L; Peters O; Incesoy EI; Spruth EJ; Priller J; Altenstein S; Bartels C; Wiltfang J; Janowitz D; Bürger K; Laske C; Munk M; Rudolph J; Glanz W; Dobisch L; Haynes JD; Dechent P; Ertl-Wagner B; Scheffler K; Kilimann I; Düzel E; Metzger CD; Wagner M; Jessen F; Teipel SJ
    Neuroimage Clin; 2021; 29():102533. PubMed ID: 33360018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint.
    Thomas KR; Weigand AJ; Edwards LC; Edmonds EC; Bangen KJ; Ortiz G; Walker KS; Bondi MW;
    Alzheimers Res Ther; 2022 Aug; 14(1):114. PubMed ID: 35996158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.